This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 2002; 28:779–798, vi.
Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and dem-onstration and counts of muscle fi bers invaded by T cells. Ann Neurol 1984;16:193–208.
Crowe WE, Bove KE, Levinson JE, Hilton PK. Clinical and pathogenetic implications of histopathology in child-hood polydermatomyositis. Arthritis Rheum 1982;25:126–139.
Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of auto-invasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984;16:0209–215.
Engel AG, Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specifi c cell-mediated cytotoxicity in some dis-eases, and implications for the pathogenesis of the differ-ent inflammatory myopathies. Hum Pathol 1986;17:704–721.
Kissel JT, Mendell JR, Rammohan KW. Microvasculature deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986;314:329–334.
Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990;27:343–356.
Estruch R, Grau JM, Fernandez-Sola J, Casademont J, Monforte R, Urbano-Marquez A. Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum Pathol 1992;23:888–895.
Figarella-Branger D, Civatte M, Bartoli C, Pellissier JF. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve 2003;28:659–682.
Goebels N, Michaelis D, Engelhardt M, et al. Differential expression of perforin in muscle-infi ltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996; 97:2905–2910.
O’Hanlon TP, Carrick DM, Arnett FC, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A,-B,-Cw,-DRB1 and-DQA1 allelic profi les and motifs defi ne clinicopathologic groups in Caucasians. Medicine (Baltimore) 2005;84:338–349.
Reed AM, Ytterberg SR. Genetic and environmental risk factors for idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002;28:891–916.
O’Hanlon TP, Carrick DM, Targoff IN, et al. HLA-A,-B,-DRB1 and-DQA1 allelic profi les for the idiopathic inflammatory myopathies: distinct immunogenetic risk and protective factors distinguish European American patients with different myositis autoantibodies. Medicine 2006;85:111–127.
Lyon MG, Bloch DA, Hollak B, Fries JF. Predisposing factors in polymyositis-dermatomyositis: results of a nationwide survey. J Rheumatol 1989;16:1218–1224.
Dalakas MC. Mechanisms of disease. Signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract Rheumatol 2006;2:219–227.
Nagaraju K, Rider LG, Fan C, et al. Endothelial cell activa-tion and neovascularization are prominent in dermato-myositis. J Autoimmune Dis 2006;3:2.
Fall N, Bove KE, Stringer K, et al. Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy. Arthritis Rheum 2005;52:3175–3180.
Tezak Z, Hoffman EP, Lutz JL, et al. Gene expression profi ling in DQA1*0501 children with untreated derma-tomyositis: a novel model of pathogenesis. J Immunol 2002;168:4154–4163.
Greenberg SA, Sanoudou D, Haslett JN, et al. Molecular profi les of inflammatory myopathies. Neurology 2002;59: 1170–1182.
Raju R, Dalakas MC. Gene expression profi le in the muscles of patients with inflammatory myopathies: effect of therapy with IVIG and biological validation of clini-cally relevant genes. Brain 2005;128:1887–1896.
Nagaraju K, Raben N, Loeffler L, et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specifi c autoantibodies. Proc Natl Acad Sci U S A 2000;97:9209–9214.
Nagaraju K, Casciola-Rosen L, Lundberg I, et al. Activa-tion of the endoplasmic reticulum stress response in auto-immune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005;52:1824–1835.
Nogalska A, Engel WK, McFerrin J, Kokame K, Komano H, Askanas V. Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers. J Neurochem 2006;96: 1491–1499.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC.
About this chapter
Cite this chapter
Rider, L.G., Miller, F.W. (2008). Idiopathic Inflammatory Myopathies. In: Klippel, J.H., Stone, J.H., Crofford, L.J., White, P.H. (eds) Primer on the Rheumatic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68566-3_47
Download citation
DOI: https://doi.org/10.1007/978-0-387-68566-3_47
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-35664-8
Online ISBN: 978-0-387-68566-3
eBook Packages: MedicineMedicine (R0)